A novel germline inactivating mutation in the CASR gene in an Italian kindred affected by familial hypocalciuric hypercalcemia

Alberto Falchetti, Alessia Gozzini, Annalisa Terranegra, Laura Soldati, Giuseppe Vezzoli, Gigliola Leoncini, Francesca Giusti, Francesco Franceschelli, Laura Masi, Annalisa Tanini, Loredana Cavalli, Maria Luisa Brandi

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

Objective: Familial hypocalciuric hypercalcemia (FHH) syndrome is a rare benign condition, inherited as an autosomal dominant trait, in which inactivating mutations of the calcium-sensing receptor (CASR) gene affects the body's ability to regulate calcium homeostasis. Its outcome is featured by increased levels of serum calcium, moderate hypophosphatemia, and inadequately normal or elevated circulating parathyroid hormone levels. Affected patients are mostly asymptomatic and do not benefit from surgical resection of their mildly enlarged parathyroids. Design: We evaluated for hypercalcemia an Italian family that was identified via a young adult male proband referred to our center for parathyroidectomy. Methods: The patients and the family members were evaluated both biochemically and genetically as suspected FHH subjects. An in vitro functional study was performed by site-directed mutagenesis, and CASR activity was monitored by measuring intracellular calcium ([Ca2+] i). Results: The patient had a novel germline heterozygous CASR mutation (c.361-364GATT; p.D121del/fsX122). The mutation caused a premature stop codon at codon 122, exiting a truncated protein. The biochemical phenotype of all family members carrying the heterozygous deletion was concordant with classic FHH syndrome. Conclusions: Our findings confirm the role of CASR gene mutational analysis to offer a valuable addition for the recognition of FHH in hypercalcemic patients not yet characterized for a positive familial history of hypercalcemia, the only condition that identifies CASR gene mutations in hypercalcemia.

Original languageEnglish
Pages (from-to)933-940
Number of pages8
JournalEuropean Journal of Endocrinology
Volume166
Issue number5
DOIs
Publication statusPublished - May 2012
Externally publishedYes

Fingerprint

Calcium-Sensing Receptors
Germ-Line Mutation
Hypercalcemia
Mutation
Genes
Calcium
Hypophosphatemia
Parathyroidectomy
Aptitude
Nonsense Codon
Site-Directed Mutagenesis
Parathyroid Hormone
Codon
Young Adult
Homeostasis
Hypocalciuric hypercalcemia, familial, type 1
Phenotype
Serum
Proteins

ASJC Scopus subject areas

  • Endocrinology, Diabetes and Metabolism
  • Endocrinology

Cite this

A novel germline inactivating mutation in the CASR gene in an Italian kindred affected by familial hypocalciuric hypercalcemia. / Falchetti, Alberto; Gozzini, Alessia; Terranegra, Annalisa; Soldati, Laura; Vezzoli, Giuseppe; Leoncini, Gigliola; Giusti, Francesca; Franceschelli, Francesco; Masi, Laura; Tanini, Annalisa; Cavalli, Loredana; Brandi, Maria Luisa.

In: European Journal of Endocrinology, Vol. 166, No. 5, 05.2012, p. 933-940.

Research output: Contribution to journalArticle

Falchetti, A, Gozzini, A, Terranegra, A, Soldati, L, Vezzoli, G, Leoncini, G, Giusti, F, Franceschelli, F, Masi, L, Tanini, A, Cavalli, L & Brandi, ML 2012, 'A novel germline inactivating mutation in the CASR gene in an Italian kindred affected by familial hypocalciuric hypercalcemia', European Journal of Endocrinology, vol. 166, no. 5, pp. 933-940. https://doi.org/10.1530/EJE-11-0953
Falchetti, Alberto ; Gozzini, Alessia ; Terranegra, Annalisa ; Soldati, Laura ; Vezzoli, Giuseppe ; Leoncini, Gigliola ; Giusti, Francesca ; Franceschelli, Francesco ; Masi, Laura ; Tanini, Annalisa ; Cavalli, Loredana ; Brandi, Maria Luisa. / A novel germline inactivating mutation in the CASR gene in an Italian kindred affected by familial hypocalciuric hypercalcemia. In: European Journal of Endocrinology. 2012 ; Vol. 166, No. 5. pp. 933-940.
@article{52adf76acd08465ca8fead9e15bb4285,
title = "A novel germline inactivating mutation in the CASR gene in an Italian kindred affected by familial hypocalciuric hypercalcemia",
abstract = "Objective: Familial hypocalciuric hypercalcemia (FHH) syndrome is a rare benign condition, inherited as an autosomal dominant trait, in which inactivating mutations of the calcium-sensing receptor (CASR) gene affects the body's ability to regulate calcium homeostasis. Its outcome is featured by increased levels of serum calcium, moderate hypophosphatemia, and inadequately normal or elevated circulating parathyroid hormone levels. Affected patients are mostly asymptomatic and do not benefit from surgical resection of their mildly enlarged parathyroids. Design: We evaluated for hypercalcemia an Italian family that was identified via a young adult male proband referred to our center for parathyroidectomy. Methods: The patients and the family members were evaluated both biochemically and genetically as suspected FHH subjects. An in vitro functional study was performed by site-directed mutagenesis, and CASR activity was monitored by measuring intracellular calcium ([Ca2+] i). Results: The patient had a novel germline heterozygous CASR mutation (c.361-364GATT; p.D121del/fsX122). The mutation caused a premature stop codon at codon 122, exiting a truncated protein. The biochemical phenotype of all family members carrying the heterozygous deletion was concordant with classic FHH syndrome. Conclusions: Our findings confirm the role of CASR gene mutational analysis to offer a valuable addition for the recognition of FHH in hypercalcemic patients not yet characterized for a positive familial history of hypercalcemia, the only condition that identifies CASR gene mutations in hypercalcemia.",
author = "Alberto Falchetti and Alessia Gozzini and Annalisa Terranegra and Laura Soldati and Giuseppe Vezzoli and Gigliola Leoncini and Francesca Giusti and Francesco Franceschelli and Laura Masi and Annalisa Tanini and Loredana Cavalli and Brandi, {Maria Luisa}",
year = "2012",
month = "5",
doi = "10.1530/EJE-11-0953",
language = "English",
volume = "166",
pages = "933--940",
journal = "European Journal of Endocrinology",
issn = "0804-4643",
publisher = "BioScientifica Ltd.",
number = "5",

}

TY - JOUR

T1 - A novel germline inactivating mutation in the CASR gene in an Italian kindred affected by familial hypocalciuric hypercalcemia

AU - Falchetti, Alberto

AU - Gozzini, Alessia

AU - Terranegra, Annalisa

AU - Soldati, Laura

AU - Vezzoli, Giuseppe

AU - Leoncini, Gigliola

AU - Giusti, Francesca

AU - Franceschelli, Francesco

AU - Masi, Laura

AU - Tanini, Annalisa

AU - Cavalli, Loredana

AU - Brandi, Maria Luisa

PY - 2012/5

Y1 - 2012/5

N2 - Objective: Familial hypocalciuric hypercalcemia (FHH) syndrome is a rare benign condition, inherited as an autosomal dominant trait, in which inactivating mutations of the calcium-sensing receptor (CASR) gene affects the body's ability to regulate calcium homeostasis. Its outcome is featured by increased levels of serum calcium, moderate hypophosphatemia, and inadequately normal or elevated circulating parathyroid hormone levels. Affected patients are mostly asymptomatic and do not benefit from surgical resection of their mildly enlarged parathyroids. Design: We evaluated for hypercalcemia an Italian family that was identified via a young adult male proband referred to our center for parathyroidectomy. Methods: The patients and the family members were evaluated both biochemically and genetically as suspected FHH subjects. An in vitro functional study was performed by site-directed mutagenesis, and CASR activity was monitored by measuring intracellular calcium ([Ca2+] i). Results: The patient had a novel germline heterozygous CASR mutation (c.361-364GATT; p.D121del/fsX122). The mutation caused a premature stop codon at codon 122, exiting a truncated protein. The biochemical phenotype of all family members carrying the heterozygous deletion was concordant with classic FHH syndrome. Conclusions: Our findings confirm the role of CASR gene mutational analysis to offer a valuable addition for the recognition of FHH in hypercalcemic patients not yet characterized for a positive familial history of hypercalcemia, the only condition that identifies CASR gene mutations in hypercalcemia.

AB - Objective: Familial hypocalciuric hypercalcemia (FHH) syndrome is a rare benign condition, inherited as an autosomal dominant trait, in which inactivating mutations of the calcium-sensing receptor (CASR) gene affects the body's ability to regulate calcium homeostasis. Its outcome is featured by increased levels of serum calcium, moderate hypophosphatemia, and inadequately normal or elevated circulating parathyroid hormone levels. Affected patients are mostly asymptomatic and do not benefit from surgical resection of their mildly enlarged parathyroids. Design: We evaluated for hypercalcemia an Italian family that was identified via a young adult male proband referred to our center for parathyroidectomy. Methods: The patients and the family members were evaluated both biochemically and genetically as suspected FHH subjects. An in vitro functional study was performed by site-directed mutagenesis, and CASR activity was monitored by measuring intracellular calcium ([Ca2+] i). Results: The patient had a novel germline heterozygous CASR mutation (c.361-364GATT; p.D121del/fsX122). The mutation caused a premature stop codon at codon 122, exiting a truncated protein. The biochemical phenotype of all family members carrying the heterozygous deletion was concordant with classic FHH syndrome. Conclusions: Our findings confirm the role of CASR gene mutational analysis to offer a valuable addition for the recognition of FHH in hypercalcemic patients not yet characterized for a positive familial history of hypercalcemia, the only condition that identifies CASR gene mutations in hypercalcemia.

UR - http://www.scopus.com/inward/record.url?scp=84862067553&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84862067553&partnerID=8YFLogxK

U2 - 10.1530/EJE-11-0953

DO - 10.1530/EJE-11-0953

M3 - Article

C2 - 22315359

AN - SCOPUS:84862067553

VL - 166

SP - 933

EP - 940

JO - European Journal of Endocrinology

JF - European Journal of Endocrinology

SN - 0804-4643

IS - 5

ER -